All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
UHS / Universal Health Services, Inc.
|
|
|
|
|
|
|
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
MCK / McKesson Corporation
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
GRTS / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
PRVA / Privia Health Group, Inc.
|
|
|
|
|
|
|
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
/ Exscientia plc
|
|
|
|
|
|
|
|
MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
/ CareMax Inc
|
|
|
|
|
|
|
|
SDGR / Schrödinger, Inc.
|
|
|
|
|
|
|
|
COR / Cencora, Inc.
|
|
|
|
|
|
|
|
AIP / Arteris, Inc.
|
|
|
|
|
|
|
|
BHC / Bausch Health Companies Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
SLP / Simulations Plus, Inc.
|
|
|
|
|
|
|
|
VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
/ GE HealthCare Technologies, Inc.
|
|
|
|
|
|
|
|
PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
IPSC / Century Therapeutics, Inc.
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
CVAC / CureVac N.V.
|
|
|
|
|
|
|
|
TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIO / Bio-Rad Laboratories, Inc.
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
DNLI / Denali Therapeutics Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
ALT / Altimmune, Inc.
|
|
|
|
|
|
|
|
HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
EDIT / Editas Medicine, Inc.
|
|
|
|
|
|
|
|
RYZB / RayzeBio, Inc.
|
|
|
|
|
|
|
|
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ANTX / AN2 Therapeutics, Inc.
|
|
|
|
|
|
|
|
SGRY / Surgery Partners, Inc.
|
|
|
|
|
|
|
|
ACIU / AC Immune SA
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
ZTS / Zoetis Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
DHR / Danaher Corporation
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
NMRA / Neumora Therapeutics, Inc.
|
|
|
|
|
|
|
|
THC / Tenet Healthcare Corporation
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRBU / Caribou Biosciences, Inc.
|
|
|
|
|
|
|
|